Moreover, we found that p22phox was highly expressed in carcinoma areas of the three CDDP-resistant cases (Figure 1B–1D or Table 1, patients 4–6), but was nearly absent in those of the three CDDP-sensitive cases (Figure 1F–1H or Table 1, patients 1–3). This evidence concerns the gene CYBA and carcinoma.